Apocrine lesions of the breast: part 2 of a two-part review. Invasive apocrine carcinoma, the molecular apocrine signature and utility of immunohistochemistry in the diagnosis of apocrine lesions of the breast

Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor–Positive Subset of Triple-Negative Breast Cancers

(2016) Anne M. Mills et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Atypical Apocrine Adenosis: Diagnostic Challenges and Pitfalls

(2016) Jaya Ruth Asirvatham et al.   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE

Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer

(2016) Erik Hilborn et al.   BRITISH JOURNAL OF CANCER

Genetic alterations of triple negative breast cancer by targeted next-generation sequencing and correlation with tumor morphology

(2016) Paul S Weisman et al.   MODERN PATHOLOGY

Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection

(2016) Brian D. Lehmann et al.   PLoS One

Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast

(2015) Semir Vranic et al.   HUMAN PATHOLOGY

A Functionally Significant Cross-talk between Androgen Receptor and ErbB2 Pathways in Estrogen Receptor Negative Breast Cancer

(2015) Ali Naderi et al.   NEOPLASIA

Androgen Receptor Expression Predicts Decreased Survival in Early Stage Triple-Negative Breast Cancer

(2014) Jung Eun Choi et al.   ANNALS OF SURGICAL ONCOLOGY

Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes

(2014) Silvia Darb-Esfahani et al.   BMC CANCER

Tackling the Diversity of Triple-Negative Breast Cancer

(2013) N. C. Turner et al.   CLINICAL CANCER RESEARCH

Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer

(2013) A. Gucalp et al.   CLINICAL CANCER RESEARCH

Immunohistochemically Defined Subtypes and Outcome of Apocrine Breast Cancer

(2012) Silvia Dellapasqua et al.   Clinical Breast Cancer

Apocrine Carcinoma as Triple-negative Breast Cancer: Novel Definition of Apocrine-type Carcinoma as Estrogen/Progesterone Receptor-negative and Androgen Receptor-positive Invasive Ductal Carcinoma

(2012) Y. Tsutsumi   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

Androgen receptor in triple negative breast cancer

(2012) K.M. McNamara et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

The Clinicopathologic Features of Molecular Apocrine Breast Cancer

(2012) Yoon Jin Cha et al.   Korean Journal of Pathology

Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy

(2011) GÁBOR CSERNI   APMIS

Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer

(2011) Min Ni et al.   CANCER CELL

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

(2011) Brian D. Lehmann et al.   JOURNAL OF CLINICAL INVESTIGATION

Histiocytoid breast carcinoma: an enigmatic lobular entity

(2011) P. H. Tan et al.   JOURNAL OF CLINICAL PATHOLOGY

Prognostic value of androgen receptor expression in operable triple-negative breast cancer: a retrospective analysis based on a tissue microarray

(2011) Jiehua He et al.   MEDICAL ONCOLOGY

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

(2011) Laura C Collins et al.   MODERN PATHOLOGY

A refined molecular taxonomy of breast cancer

(2011) M Guedj et al.   ONCOGENE

EGFR and HER-2/neu expression in invasive apocrine carcinoma of the breast

(2010) Semir Vranic et al.   MODERN PATHOLOGY

Expression of androgen receptors in primary breast cancer

(2009) S. Park et al.   ANNALS OF ONCOLOGY

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

(2009) Leo A Niemeier et al.   MODERN PATHOLOGY